|
|
||||||||
From the Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115 and the McLaughlin Research Institute, Great Falls, Montana 59401
Abstract
(B10.A x B10.S)F1 hybrid mice produce lower levels of anti-GL
antibody than B10.S(9R) and B10.HTT mice. To determine whether this difference is due to a gene dose or a cis-trans effect, [B10.S(9R) x B10.S(8R)]F1 mice were immunized with GL
. These mice carry one dose of the responder Ir gene alleles in the cis position whereas the recombinant B10.S(9R) and B10.HTT mice carry two doses of the relevant genes. Both (B10.A x B10.S) and [B10.S(9R) x B10.S(8R)] F1 mice produced comparably lower amounts of antibodies as compared to the recombinant strains. The data therefore demonstrate that gene dose and not cis-trans effect accounts for the differences between F1 and recombinant strains in their antibody response to GL
controlled by complementary Ir genes.
This article has been cited by other articles:
![]() |
P. Ilmonen, D. J. Penn, K. Damjanovich, L. Morrison, L. Ghotbi, and W. K. Potts Major Histocompatibility Complex Heterozygosity Reduces Fitness in Experimentally Infected Mice Genetics, August 1, 2007; 176(4): 2501 - 2508. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wedekind, M. Walker, and T. J. Little The Course of Malaria in Mice: Major Histocompatibility Complex (MHC) Effects, but No General MHC Heterozygote Advantage in Single-Strain Infections Genetics, July 1, 2005; 170(3): 1427 - 1430. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |